drugset
drugset / Trial / NCT06841926

Study to Evaluate the Pharmacokinetics and Relative Bioavailability of Metabolites in Healthy Chinese Adult Males

NCT06841926 ↗

Phase 1 Completed 40 enrolled Nanjing Zenshine Pharmaceuticals
RandomizedCrossoverOpen-labelTreatment

Summary

Study to evaluate the pharmacokinetics and relative bioavailability of metabolites in healthy Chinese adult males

Timeline

Start
2025-02-20
Primary completion
2025-04-18
Completion
2025-04-18

Drugs

EvaluationDrugModalityDoseRoute
Subject ZX-7101A Unknown 40 mg —

Indications

viral respiratory tract infection